Greenleaf Trust’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Greenleaf Trust’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,404	Closed	-$74K	–	618
2019 Q4	$74K	Hold	5,404	–	–	﹤0.01%	545
2019 Q3	$84K	Hold	5,404	–	–	﹤0.01%	550
2019 Q2	$121K	Hold	5,404	–	–	﹤0.01%	532
2019 Q1	$370K	Hold	5,404	–	–	0.01%	336
2018 Q4	$285K	Hold	5,404	–	–	0.01%	375
2018 Q3	$368K	Hold	5,404	–	–	0.01%	340
2018 Q2	$640K	Hold	5,404	–	–	0.01%	224
2018 Q1	$447K	Buy	5,404 +206	+4%	+$23.4K	0.01%	257
2017 Q4	$776K	Sell	5,198 -93	-2%	-$8.94K	0.02%	183
2017 Q3	$328K	Sell	5,291 -250	-5%	-$14.7K	0.01%	293
2017 Q2	$259K	Buy	5,541 +188	+4%	+$9.6K	0.01%	301
2017 Q1	$328K	Hold	5,353	–	–	0.01%	210
2016 Q4	$319K	Buy	5,353 +508	+10%	+$31.7K	0.01%	172
2016 Q3	$353K	Sell	4,845 -341	-7%	-$26.4K	0.01%	142
2016 Q2	$413K	Buy	5,186 +374	+8%	+$71.3K	0.01%	119
2016 Q1	$1.3M	Buy	4,812 +42	+0.9%	+$13.4K	0.04%	79
2015 Q4	$2.87M	Buy	4,770 +2,345	+97%	+$1.59M	0.09%	53
2015 Q3	$1.99M	Buy	+2,425	New	+$2.73M	0.06%	44

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Abingworth London, United Kingdom $304M AUM 95.02% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 33.95% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Greenleaf Trust's SRRA Position: Q1 2020 in Review

Greenleaf Trust sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 5,404 shares — an estimated $74K sold.

Greenleaf Trust first reported a position in SRRA in Q3 2015 and held it in 18 quarters. The position peaked at $2.87M in Q4 2015. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

Greenleaf Trust reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Greenleaf Trust sold 5,404 Sierra Oncology, Inc. Common Stock shares in Q1 2020, an estimated $74K.
Greenleaf Trust first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 18 quarters.
Greenleaf Trust's Sierra Oncology, Inc. Common Stock position peaked at $2.87M in Q4 2015.
22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Greenleaf Trust's 13F filing for Q1 2020, filed 29 Apr 2020.